# Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions

> **NCT03268239** · NA · COMPLETED · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 180 (actual)

## Conditions studied

- Magnetic Resonance Imaging
- Central Nervous System
- Brain
- Multiple Sclerosis
- Demyelinating Diseases

## Interventions

- **DEVICE:** Additional MRI sequences

## Key facts

- **NCT ID:** NCT03268239
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-02
- **Primary completion:** 2021-04-26
- **Final completion:** 2021-04-26
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03268239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03268239, "Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03268239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*